Omada Health targets at least 20% annual revenue growth, 30% adjusted EBITDA margin long term

• Omada set long-term targets at Investor Day, including at least 20% annual revenue growth.
• Outlook calls for 80% non-GAAP gross margin, up from 70% on a trailing 12-month basis through June 30, 2026.
• Forecast includes a 30% adjusted EBITDA margin, versus 7% over the same trailing period.
• Scale backdrop: member base rose to 1,090,000 from about 300,000 since 2023; revenue increased to $310 million from about $123 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omada Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609100900PRIMZONEFULLFEED9824292) on September 10, 2026, and is solely responsible for the information contained therein.